Spire Healthcare Group plc
('Spire Healthcare', 'the Company' or 'the Group')
Notice of Interim Results
15 August 2022
Spire Healthcare Group plc (LSE: SPI), a leading independent hospital group in the UK, will announce its interim results for the six months ended 30 June 2022 on Thursday 8 September 2022.
A Zoom webcast presentation for sell-side analysts and investors will be held at 9.00am BST on 8 September. If you wish to attend the webinar, please register in advance at https://spirehealthcare.zoom.us/webinar/register/WN_7PsBnqaqTPmJy0j2dI-PMA
- Ends -
For further information please contact:
Spire Healthcare |
|
|
Angus Prentice - Interim Head of Investor Relations |
|
+44 (0)7974 982 512 |
|
|
|
Instinctif Partners |
|
|
Damian Reece |
|
+44 (0)7931 598 593 |
Guy Scarborough |
|
+44 (0)7917 178 920 |
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and eight clinics across England, Wales and Scotland.
Working in partnership with around 8,150 experienced Consultants, Spire Healthcare delivered tailored, personalised care to almost 870,000 in-patients and daycase patients in 2021, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.
The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers.
Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.